MiR-30a suppresses metastasis of gastric adenocarcinoma via targeting FAP α.

CONCLUSION: MiR-30a inhibited gastric cancer metastasis by targeting FAPα, suggesting that miR-30a may function as a novel tumor suppressor in gastric cancer. PMID: 32116236 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32116236?dopt=Abstract

Source: Cancer Biomarkers - March 3, 2020 Category: Cancer & Oncology Tags: Cancer Biomark Source Type: research

More News: Adenocarcinoma | Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology